1. Home
  2. Stock quotes
  3. Stock Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated LGND

$ 204.81 -2.7%

Quarterly report 2025-Q3
added 11-07-2025

report update icon

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBALSPB

Shares

 18.3 M

Market Cap[1]

 $ 3.75 B

EBITDA (LTM)

 $ 60.8 M

P/E (LTM)

 56.27

P/S (LTM)

 14.39

EPS (LTM)

 3.64

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
 		$ 221.88 -0.87 % $ 5 B Nasdaq Global Select Market danmarkDanmark
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Pharming Group N.V. Pharming Group N.V.
PHAR
 		$ 15.36 -0.71 % $ 7.59 B Nasdaq Global Select Market niderlandNiderland
I-Mab I-Mab
IMAB
 		- - $ 866 M Nasdaq Global Select Market chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
 		- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Inventiva S.A. Inventiva S.A.
IVA
 		$ 5.78 -4.3 % $ 138 M Nasdaq Global Market franceFrance
Biophytis SA Biophytis SA
BPTS
 		- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
 		$ 1.21 -3.97 % $ 71.5 M Nasdaq Global Market britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
 		$ 2.28 -0.44 % $ 1.03 M Nasdaq Capital Market israelIsrael
ARCA biopharma ARCA biopharma
ABIO
 		- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
 		- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
Acasti Pharma Acasti Pharma
ACST
 		- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		- - - MOEX russiaRussia
Assembly Biosciences Assembly Biosciences
ASMB
 		$ 28.46 3.45 % $ 319 M Nasdaq Global Select Market,SPB usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
 		- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		$ 1.37 -4.2 % $ 350 M Nasdaq Global Select Market britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		- - $ 86.2 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
 		$ 156.92 -1.23 % $ 7.81 B Nasdaq Global Market,SPB usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
AbCellera Biologics AbCellera Biologics
ABCL
 		$ 3.4 -3.68 % $ 1.02 B Nasdaq Global Select Market canadaCanada
Atreca Atreca
BCEL
 		- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
 		$ 54.13 -1.64 % $ 10.4 B Nasdaq Global Select Market,SPB usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
 		$ 10.98 -4.52 % $ 452 M Nasdaq Capital Market usaUSA
Calithera Biosciences Calithera Biosciences
CALA
 		- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
 		$ 2.09 -0.95 % $ 195 M Nasdaq Global Market,SPB israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
 		$ 1.52 -5.59 % $ 178 M Nasdaq Global Market usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		- - $ 169 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
 		- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		- - $ 867 M Nasdaq Global Market germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
 		$ 7.7 -5.87 % $ 1.29 B NYSE britainBritain
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
 		$ 8.6 -3.8 % $ 115 M Nasdaq Global Market usaUSA
Curis Curis
CRIS
 		$ 0.77 1.89 % $ 4.86 M Nasdaq Global Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
 		$ 3.34 -4.02 % $ 116 M Nasdaq Global Market franceFrance

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.